Selection of a respiratory syncytial virus fusion inhibitor clinical candidate. 2. Discovery of a morpholinopropylaminobenzimidazole derivative (TMC353121).
暂无分享，去创建一个
K. Andries | C. Meyer | P. Timmerman | F. Janssens | J. Bonfanti | F. Doublet | J. Fortin | P. Muller | Laurence Quéguiner | T. Gevers | Peggy Janssens | H. Szel | R. Willebrords | K. Wuyts | P. Wigerinck | P. van Remoortere | Jean-François Bonfanti | Heidi Szel | Tom Gevers